nelfinavir has been researched along with Hepatitis C in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (90.91) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyko, EJ; Bryson, CL; Ioannou, GN; Weiss, NS | 1 |
| Briganti, E; Castelli, P; Cusato, M; Delle Foglie, P; Fabris, P; Gatti, F; Maserati, R; Mori, F; Nardini, G; Regazzi, M; Roda, R; Sacchelli, L; Testa, L; Villani, P; Zucchi, P | 1 |
| Brun, S; Cernohous, P; Da Silva, B; Omachi, JH; Rouster, SD; Sherman, KE; Shire, NJ | 1 |
| Benhaim, S; Drogoul-Vey, MP; Frixon-Marin, V; Gastaut, JA; Marimoutou, C; Poggi, P; Poizot-Martin, I; Vion-Dury, F | 1 |
| Brown, LS; Chu, M; Kritz, S; Madray, C | 1 |
| Abbara, C; Barrail, A; Boissonnas, A; Bonhomme-Faivre, L; Duclos-Vallée, JC; Samuel, D; Taburet, AM; Teicher, E; Vincent, I; Vittecoq, D | 1 |
| Rudbeck, G; Schvarcz, R; Söderdahl, G; Ståhle, L | 1 |
| Arnedo, A; Gómez, CJ; Roca, B | 1 |
| Ray, SC; Sulkowski, MS; Thomas, DL | 1 |
3 trial(s) available for nelfinavir and Hepatitis C
| Article | Year |
|---|---|
Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects.
Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Area Under Curve; Biotransformation; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; HIV Seropositivity; Humans; Liver Cirrhosis; Male; Middle Aged; Nelfinavir; Quality Control; Spectrophotometry, Ultraviolet | 2005 |
Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Topics: Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Hepacivirus; Hepatitis C; HIV Infections; Humans; Liver; Lopinavir; Male; Middle Aged; Nelfinavir; Pyrimidinones; Ritonavir; RNA, Viral; Viral Load | 2005 |
Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study.
Topics: Adult; Aged; Alkynes; Antiretroviral Therapy, Highly Active; Area Under Curve; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dose-Response Relationship, Drug; Female; Graft Rejection; Half-Life; Hepatitis C; HIV; HIV Infections; Humans; Liver Transplantation; Lopinavir; Male; Middle Aged; Nelfinavir; Pyrimidinones; Ritonavir; Tacrolimus; Viral Load | 2007 |
8 other study(ies) available for nelfinavir and Hepatitis C
| Article | Year |
|---|---|
Associations between lipodystrophy or antiretroviral medications and cirrhosis in patients with HIV infection or HIV/HCV coinfection.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Case-Control Studies; Coinfection; Didanosine; Female; Hepatitis C; Hispanic or Latino; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Liver Cirrhosis; Male; Middle Aged; Nelfinavir; Reverse Transcriptase Inhibitors; Risk Factors; Stavudine; Time Factors | 2015 |
Nelfinavir tolerated in HCV patients.
Topics: Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Liver Function Tests; Nelfinavir | 2002 |
Nelfinavir safe and effective in HIV/HCV patients.
Topics: Clinical Trials as Topic; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Nelfinavir | 2003 |
Nelfinavir in HIV-HCV coinfected patients: a 24-month follow-up in a cohort of 82 patients.
Topics: Adult; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Male; Nelfinavir; Reverse Transcriptase Inhibitors; Viral Load | 2005 |
Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
Topics: Adult; Anti-HIV Agents; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Middle Aged; Nelfinavir; Opioid-Related Disorders; Retrospective Studies | 2006 |
Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV).
Topics: Drug Interactions; Drug Monitoring; Hemophilia A; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nelfinavir; Tacrolimus | 2000 |
Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients.
Topics: Adult; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Logistic Models; Male; Nelfinavir; Patient Compliance; Polymerase Chain Reaction; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Statistics, Nonparametric; Stavudine; Substance Abuse, Intravenous | 2000 |
Needlestick transmission of hepatitis C.
Topics: Accidents, Occupational; Acute Disease; Adult; Anti-HIV Agents; Antiviral Agents; Asthenia; Exanthema; Hepacivirus; Hepatitis C; Hepatitis C Antibodies; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Interferon alpha-2; Interferon-alpha; Internship and Residency; Lamivudine; Needlestick Injuries; Nelfinavir; Occupational Exposure; Physicians; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viremia; Zidovudine | 2002 |